112 related articles for article (PubMed ID: 10906424)
1. Role of perivenous hepatocytes in taurolithocholate-induced cholestasis in vivo.
Mottino A; Tuchweber B; Plaa GL; Yousef IM
Toxicol Lett; 2000 Jul; 116(1-2):69-77. PubMed ID: 10906424
[TBL] [Abstract][Full Text] [Related]
2. Phase I and phase II metabolism of lithocholic acid in hepatic acinar zone 3 necrosis. Evaluation in rats by combined radiochromatography and gas-liquid chromatography-mass spectrometry.
Dionne S; Tuchweber B; Plaa GL; Yousef IM
Biochem Pharmacol; 1994 Sep; 48(6):1187-97. PubMed ID: 7945413
[TBL] [Abstract][Full Text] [Related]
3. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
[TBL] [Abstract][Full Text] [Related]
4. Influence of agents affecting monooxygenase activity on taurolithocholic acid-induced cholestasis.
Dahlström-King L; Couture J; Plaa GL
Toxicol Lett; 1992 Dec; 63(3):243-52. PubMed ID: 1283232
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic administration of taurolithocholate on bile formation and liver ultrastructure in the rat.
Gratton F; Weber AM; Tuchweber B; Morazain R; Roy CC; Yousef IM
Liver; 1987 Jun; 7(3):130-7. PubMed ID: 3613882
[TBL] [Abstract][Full Text] [Related]
6. The influence of severity of bile flow reduction, cycloheximide, and methyl isobutyl ketone pretreatment on the kinetics of taurolithocholic acid disposition in the rat.
Dahlström-King L; du Souich P; Couture J; Plaa GL
Toxicol Appl Pharmacol; 1990 Jun; 104(2):312-21. PubMed ID: 2363182
[TBL] [Abstract][Full Text] [Related]
7. Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets.
Beuers U; Denk GU; Soroka CJ; Wimmer R; Rust C; Paumgartner G; Boyer JL
J Biol Chem; 2003 May; 278(20):17810-8. PubMed ID: 12626520
[TBL] [Abstract][Full Text] [Related]
8. Effect of endotoxin tolerance on drug hepatotoxicity: amelioration of taurolithocholate cholestasis in the perfused rat liver.
Utili R; Adinolfi LE; Gaeta GB; Tripodi MF; Alvaro D
Digestion; 1987; 36(2):74-80. PubMed ID: 3552808
[TBL] [Abstract][Full Text] [Related]
9. Bile salt independent flow during bile salt-induced choleresis and cholestasis in the rat: role of biliary thiol secretion.
Bouchard G; Tuchweber B; Yousef IM
Liver; 2000 Feb; 20(1):27-37. PubMed ID: 10726958
[TBL] [Abstract][Full Text] [Related]
10. Cholestasis induced by sodium taurolithocholate in isolated hamster liver.
King JE; Schoenfield LJ
J Clin Invest; 1971 Nov; 50(11):2305-12. PubMed ID: 5096514
[TBL] [Abstract][Full Text] [Related]
11. Reduced cholestatic potency of taurolithocholate during backward perfusion of the rat liver.
Baumgartner U; Hardison WG; Miyai K
Lab Invest; 1987 Jun; 56(6):576-82. PubMed ID: 3599905
[TBL] [Abstract][Full Text] [Related]
12. 3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.
Clerici C; Castellani D; Asciutti S; Pellicciari R; Setchell KD; O'Connell NC; Sadeghpour B; Camaioni E; Fiorucci S; Renga B; Nardi E; Sabatino G; Clementi M; Giuliano V; Baldoni M; Orlandi S; Mazzocchi A; Morelli A; Morelli O
Toxicol Appl Pharmacol; 2006 Jul; 214(2):199-208. PubMed ID: 16487557
[TBL] [Abstract][Full Text] [Related]
13. Preventive effect of silymarin against taurolithocholate-induced cholestasis in the rat.
Crocenzi FA; Sánchez Pozzi EJ; Pellegrino JM; Rodríguez Garay EA; Mottino AD; Roma MG
Biochem Pharmacol; 2003 Jul; 66(2):355-64. PubMed ID: 12826278
[TBL] [Abstract][Full Text] [Related]
14. Taurohyocholate, taurocholate, and tauroursodeoxycholate but not tauroursocholate and taurodehydrocholate counteract effects of taurolithocholate in rat liver.
Schölmerich J; Kitamura S; Baumgartner U; Miyai K; Gerok W
Res Exp Med (Berl); 1990; 190(2):121-9. PubMed ID: 2349395
[TBL] [Abstract][Full Text] [Related]
15. Different protective effects of tauroursodeoxycholate, ursodeoxycholate, and 23-methyl-ursodeoxycholate against taurolithocholate-induced cholestasis.
Baumgartner U; Schölmerich J; Sellinger M; Reinhardt M; Ruf G; Farthmann EH
Dig Dis Sci; 1996 Feb; 41(2):250-5. PubMed ID: 8601366
[TBL] [Abstract][Full Text] [Related]
16. The role of acinar zone 3 hepatocytes in bile formation: influence of bromobenzene treatment on bile formation in the rat.
Dionne S; Russo P; Tuch-Weber B; Plaa GL; Yousef IM
Liver; 1990 Apr; 10(2):85-93. PubMed ID: 2352458
[TBL] [Abstract][Full Text] [Related]
17. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
Arrese M; Pizarro M; Solís N; Koenig C; Accatino L
Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238
[TBL] [Abstract][Full Text] [Related]
18. Tauroursodeoxycholate prevents taurolithocholate-induced cholestasis and toxicity in rat liver.
Schölmerich J; Baumgartner U; Miyai K; Gerok W
J Hepatol; 1990 May; 10(3):280-3. PubMed ID: 2365980
[TBL] [Abstract][Full Text] [Related]
19. Impaired localisation and transport function of canalicular Bsep in taurolithocholate induced cholestasis in the rat.
Crocenzi FA; Mottino AD; Sánchez Pozzi EJ; Pellegrino JM; Rodríguez Garay EA; Milkiewicz P; Vore M; Coleman R; Roma MG
Gut; 2003 Aug; 52(8):1170-7. PubMed ID: 12865277
[TBL] [Abstract][Full Text] [Related]
20. Hepatic transport of organic anions in taurolithocholate-induced cholestasis in rats.
Roma MG; Penalva GL; Agüero RM; Rodríguez Garay EA
J Hepatol; 1994 May; 20(5):603-10. PubMed ID: 8071536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
